Health and Healthcare
Auxilium Scores on Pfizer Pact (AUXL, PFE)
Published:
Last Updated:
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is responding well in pre-market trading after the company signed an overseas commercialization agreement with Pfizer, Inc. (NYSE: PFE). The pact covers Auxilium’s Xiaflex, a treatment for hand and urological disorders related to hardening collagen.
The terms of the deal appear to call for an upfront payment of $75million. The company is also eligible to receive milestone payments ofup to $410 million depending upon goals and targets reached.
Auxilium is set to receive increasing tiered royalty payments onPfizer’s Xiaflex sales. This could reach up to 25% since Auxilium willmake the drug. Pfizer also expects to file for approval in the U.S.in 2009 and to file for approval in the E.U. in 2010.
As of yesterday’s close, Auxilium’s market cap was $967 million basedupon a closing bell price of $22.89. Its 52-week trading range is$15.44 to $42.75, and shares are trading up 15% at $26.50 in pre-markettrading.
Jon C. Ogg
December 18, 2008
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.